Silo Pharma SILO Stock
Silo Pharma Price Chart
Silo Pharma SILO Financial and Trading Overview
| Silo Pharma stock price | 6.13 USD |
| Previous Close | 0.43 USD |
| Open | 0.41 USD |
| Bid | 0.29 USD x 200 |
| Ask | 0.43 USD x 200 |
| Day's Range | 0.33 - 0.43 USD |
| 52 Week Range | 0.22 - 1.01 USD |
| Volume | 1.3M USD |
| Avg. Volume | 4.11M USD |
| Market Cap | 5.41M USD |
| Beta (5Y Monthly) | 0.767 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.85 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SILO Valuation Measures
| Enterprise Value | -621904 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.47514287 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 75.03632 |
| Price/Book (mrq) | 0.70317125 |
| Enterprise Value/Revenue | -8.625 |
| Enterprise Value/EBITDA | 0.13 |
Trading Information
Silo Pharma Stock Price History
| Beta (5Y Monthly) | 0.767 |
| 52-Week Change | -32.86% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1.01 USD |
| 52 Week Low | 0.22 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.47 USD |
SILO Share Statistics
| Avg. Volume (3 month) | 4.11M USD |
| Avg. Daily Volume (10-Days) | 335.3K USD |
| Shares Outstanding | 16.27M |
| Float | 15.83M |
| Short Ratio | 0.28 |
| % Held by Insiders | 5.99% |
| % Held by Institutions | 6.49% |
| Shares Short | 728.37K |
| Short % of Float | 4.66% |
| Short % of Shares Outstanding | 4.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8846.44% |
| Gross Margin | 11.89% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.26% |
| Return on Equity (ttm) | -99.93% |
Income Statement
| Revenue (ttm) | 72.1K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | 8.58K USD |
| EBITDA | -4769916 USD |
| Net Income Avi to Common (ttm) | -4843378 USD |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.03M USD |
| Total Cash Per Share (mrq) | 0.37 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 9.653 |
| Book Value Per Share (mrq) | 0.473 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3843662 USD |
| Levered Free Cash Flow (ttm) | -2667742 USD |
Profile of Silo Pharma
| Country | United States |
| State | FL |
| City | Sarasota |
| Address | 677 North Washington Boulevard |
| ZIP | 34236 |
| Phone | 718 400 9031 |
| Website | https://silopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Q&A For Silo Pharma Stock
What is a current SILO stock price?
Silo Pharma SILO stock price today per share is 6.13 USD.
How to purchase Silo Pharma stock?
You can buy SILO shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Silo Pharma?
The stock symbol or ticker of Silo Pharma is SILO.
Which industry does the Silo Pharma company belong to?
The Silo Pharma industry is Biotechnology.
How many shares does Silo Pharma have in circulation?
The max supply of Silo Pharma shares is 1.08M.
What is Silo Pharma Price to Earnings Ratio (PE Ratio)?
Silo Pharma PE Ratio is now.
What was Silo Pharma earnings per share over the trailing 12 months (TTM)?
Silo Pharma EPS is -5.85 USD over the trailing 12 months.
Which sector does the Silo Pharma company belong to?
The Silo Pharma sector is Healthcare.
Silo Pharma SILO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
- {{ link.label }} {{link}}